Flushing out antibodies to make AAV gene therapy available to more patients

Molecular Therapy

Volumn 21, Issue 2, 2013, Pages 269-271

  Raper, Steven E ^a   Wilson, James M ^a   Nunes, Frederick A ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PENNSYLVANIA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ADENO ASSOCIATED VIRUS; ANTIBODY TITER; DISEASE SEVERITY; GENE EXPRESSION REGULATION; GENE TRANSFER; HEMOPHILIA A; HEMOPHILIA B; HEPATIC ARTERY; HUMAN; LIVER BLOOD FLOW; MINIMALLY INVASIVE SURGERY; NATURAL ORIFICE TRANSLUMINAL ENDOSCOPIC SURGERY; NONHUMAN; NOTE; PLASMAPHERESIS; VASOCONSTRICTION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS IMMUNITY;

EID: 84873333087     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.5     Document Type: Note

References (17)

1. High, KA (2012). The gene therapy journey for hemophilia: are we there yet? Blood 120: 4482-4487.
2. Nathwani, AC, Tuddenham, EG, Rangarajan, S, Rosales, C, McIntosh, J, Linch, DC et al. (2011). Ade-novirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med 365: 2357-2365.
3. Wang, L, Calcedo, R, Wang, H, Bell, P, Grant, R, Van-denberghe, LH et al. (2010). The pleiotropic effects of natural AAV infections on liver-directed gene transfer in macaques. Mol Ther 18: 126-134.
4. Wang, L, Calcedo, R, Bell, P, Lin, J, Grant, RL, Siegel, D et al. (2011). Impact of pre-existing immunity on gene transfer to nonhuman primate liver with adeno-associated virus 8 vectors. Hum Gene Ther 22: 1389-1401.
5. Mimuro, J, Mizukami, H, Hishikawa, S, Ikemoto, T, Ishiwata, A, Sakata, A et al. (2013). Minimizing the inhibitory effect of neutralizing antibody for effcient gene expression in the liver with adeno-associated virus 8 vectors. Mol Ther 21: 318-323.
6. Raper, SE (2011). Substrate metabolism in surgery. In: Mulholland, MW, Lillemoe, KD, Doherty, GM, Maier, RV, Simeone, DM and Upchurch, GR (eds). Green-feld's Surgery: Scientifc Principles and Practice, 5th edn. Wolters Kluwer Health/Lippincott Williams & Wilkins: Philadelphia, PA, pp 36-55.
7. Mannucci, PM and Tuddenham, EGD (2001). Medical progress: the hemophilias-from royal genes to gene therapy. N Engl J Med 344: 1773-1779.
8. Wang, L, Wang, H, Bell, P, McCarter, RJ, He, J, Calcedo, R et al. (2010). Systematic evaluation of AAV vectors for liver directed gene transfer in murine models. Mol Ther 18: 118-125.
9. Lautt, WW and Greenway, CV (1987). Conceptual review of the hepatic vascular bed. Hepatology 7: 952-963.
10. Fraker, DL, Alexander, HR and Thom AK (1994). Use of tumor necrosis factor in isolated hepatic perfusion. Circ Shock 44: 45-50.
11. Alexander, HR, Bartlett, DL, Libutti, SK, Fraker, DL, Moser, T and Rosenberg, SA (1998). Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable hepatic metastases confned to the liver. J Clin Oncol 16: 1479-1489.
12. Kalloo, AN, Singh, VK, Jagannath, SB, Niiyama, H, Hill, SL, Vaughn, CA et al. (2004). Flexible transgas-tric peritoneoscopy: a novel approach to diagnostic and therapeutic interventions in the peritoneal cavity. Gastrointest Endosc 60: 114-117.
13. Hurlbut, GD, Ziegler, RJ, Nietupski, JB, Foley, JW, Woodworth, LA and Meyers, E et al. (2010). Preexisting immunity and low expression in primates highlight translational challenges for liver-directed AAV8-mediated gene therapy. Mol Ther 18: 1983-1994.
14. Boone, BA, Bartlett, DL and Zureikat, AH (2012). Isolated hepatic perfusion for the treatment of liver metastases. Curr Probl Cancer 36: 27-76.
15. Libutti, SK, Bartlett, DL, Fraker, DL and Alexander, HR (2000). Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis and melphalan for the treatment of unresectable hepatic malignancies. J Am Coll Surg 191: 519-530.
16. Maleux, G, Monbaliu, D, Verslype, C, Casteleyn, C, Van de Velde, M, Cornillie, P et al. (2010). Percutaneous isolated liver perfusion with occlusion balloons and a catheter-based stent-graft-like perfusion device: an experimental study in a porcine model. Eur Radiol 20: 2372-2380.
17. van Etten, B, Eggermont, AMM, van Tiel, ST, Ambagtsheer, G, de Wilt, JHW and ten Hagen, TLM (2005). Gene therapy in in vivo isolated perfusion models. Curr Gene Ther 5: 195-202.